Eren Ozcagli - Toxicology

Author Information

Dr. Eren Ozcagli is affiliated with the Department of Pharmaceutical Toxicology at the Faculty of Pharmacy, Istanbul University, located in Istanbul, Turkey. Dr. Ozcagli has made significant contributions to the field of toxicology, particularly in the areas of oxidative stress, DNA damage, and the impact of various toxic agents on biological systems.

Research Contributions

Dr. Eren Ozcagli's research spans a wide range of topics within toxicology. Notable works include the study of oxidative stress and DNA damage in radiology technicians, the effects of copper intoxication on the microalga Porphyridium purpureum, and the exploration of health-based exposure limits in the pharmaceutical industry. Dr. Ozcagli has also investigated the implications of CYP2D6 haplotypes for genotyping panels and explored therapeutic options against cisplatin-induced nephrotoxicity. Additionally, Dr. Ozcagli has contributed to understanding how infections with Human Papillomavirus 16 and 18 impact DNA damage and repair mechanisms in cervical cells and peripheral blood.

Aliases

Dr. Eren Ozcagli is also known by the aliases E. Ozcagli and E Ozcagli.

Publication and Citation Metrics

Metric	Value
Citation Count	639
H-Index	15
Paper Count	52

Publications:

The association of oxidative stress and DNA damage with XRCC1 and XRCC3 polymorphisms in radiology technicians

DOI: 10.1177/07482337211062680

Year: 2022

Porphyridium purpureum microalga physiological and ultrastructural changes under copper intoxication

DOI: 10.1016/j.toxrep.2021.04.015

Year: 2021

List of contributors

DOI: 10.1016/b978-0-323-85215-9.00058-1

Year: 2021

Health-based exposure limits and toxicology in the pharmaceutical industry

DOI: 10.1016/b978-0-323-85215-9.00031-3

Year: 2021

Chapter 40. Turkey

DOI:

Year: 2020

List of Contributors

DOI: 10.1016/b978-0-12-821611-8.00053-x

Year: 2020

Turkey

DOI: 10.1016/b978-0-12-821611-8.00040-1

Year: 2020

CYP2D6 haplotypes with enhancer single-nucleotide polymorphism rs5758550 and rs16947 (*2 allele): implications for CYP2D6 genotyping panels

DOI: 10.1097/FPC.0000000000000363

Year: 2019

Celastrol pretreatment as a therapeutic option against cisplatin-induced nephrotoxicity.

DOI: 10.1039/C9TX00141G

Year: 2019

How Does Infection with Human Papillomavirus 16 and 18 Impact on DNA Damage and Repair in Cervical Cells and Peripheral Blood?

DOI: 10.1089/omi.2018.0065

Year: 2018

How is MCADD Diagnosed?

How is Chronic Toxicity Testing Conducted?

Why Study Venomous Animals in Toxicology?

What Strategies are Used to Mitigate Exposure?

What are the benefits of high-throughput screening in toxicology?

How Does Open Peer Review Benefit Authors and Reviewers?

How Does Machine Learning Work in Toxicology?

Why are Dose-Response Curves Important?

Are There Limitations to Using CRP in Toxicology?

What is Persistence?

Partnered Content Networks

Relevant Topics